英文名稱 |
中文名稱 |
CAS號 |
操作 |
TPX-0005 |
洛普替尼 |
1802220-02-5 |
詳細
|
Gilteritinib |
吉列替尼 |
1254053-43-4 |
詳細
|
Glasdegib |
格拉斯吉布 |
1095173-27-5 |
詳細
|
Capmatinib 2HCl |
卡馬替尼鹽酸鹽 |
1197376-85-4 |
詳細
|
Sotorasib |
AMG510 單一構型 |
2296729-00-3 |
詳細
|
Lorlatinib |
勞拉替尼 |
1454846-35-5 |
詳細
|
BMS-986177 |
BMS-986165 |
1802425-99-5 |
詳細
|
Remibrutinib |
LOU-064 |
1787294-07-8 |
詳細
|
Ondansetron hydrochloride |
鹽酸昂丹司瓊 |
103639-04-9 |
詳細
|
CNV 1014802 hydrochloride |
(2S,5R)-5-(4-((2-氟芐基)氧基)苯基)吡咯烷-2-甲酰胺鹽酸鹽 |
934240-31-0 |
詳細
|
Silybin A |
水飛薊賓 |
22888-70-6 |
詳細
|
Rocatinlimab |
諾卡替利單抗 |
2431972-52-8 |
詳細
|
6-OH-BTA-1 |
6-OH-BTA-1 |
566169-93-5 |
詳細
|
Mirikizumab |
Mirikizumab |
1884201-71-1 |
詳細
|
Ponatinib Mono-hydrochloride |
泊那替尼鹽酸鹽 |
1114544-31-8 |
詳細
|
Formoterol fumarate dihydrate |
富馬酸福莫特羅二水合物 |
183814-30-4 |
詳細
|
Ponatinib |
帕納替尼 |
943319-70-8 |
詳細
|
Research Grade Sotatercept (DHC33102) |
|
1001080-50-7 |
詳細
|
Research Grade Bamlanivimab (DVV00303) |
BAMLANIVIMAB |
2423943-37-5 |
詳細
|
Pyrotinib dimaleate |
馬來酸吡咯替尼 |
1397922-61-0 |
詳細
|
GLP-1 |
胰高血糖素樣肽-1(GLP-1) |
87805-34-3 |
詳細
|
Sabatolimab |
SABATOLIMAB |
2252262-24-9 |
詳細
|
orellanine |
orellanine |
37338-80-0 |
詳細
|
MRTX-1257 |
MRTX-1257 |
2206736-04-9 |
詳細
|
MRTX 9768 |
MRTX 9768 |
2629314-68-5 |
詳細
|
Melatonine |
褪黑素 |
73-31-4 |
詳細
|
AG-270 |
6-(3-甲氧基苯基)-4-甲基-2-(2-嗎啉代乙基)噠嗪-3(2H)-酮鹽酸鹽 |
13299-99-5 |
詳細
|
Magrolimab |
MAGROLIMAB (莫洛利單抗 ) |
2169232-81-7 |
詳細
|
MRTX0902 |
MRTX0902 |
2654743-22-1 |
詳細
|
Adagrasib |
MRTX-849 |
2326521-71-3 |
詳細
|
Research Grade Anti-Human CD152 |
|
|
詳細
|
Research Grade Acazicolcept |
單抗 |
2270247-50-0 |
詳細
|
Glumetinib |
谷美替尼 |
1642581-63-2 |
詳細
|
Research Grade Anti-Human CD19 |
|
|
詳細
|
OUL 35 |
4,4'-Oxybis[benzamide] |
6336-34-1 |
詳細
|
GR 89696 fumarate |
GR 89696 FUMARATE |
126766-32-3 |
詳細
|
MYK-461 |
瑪伐凱泰 |
1642288-47-8 |
詳細
|
Chidamide |
西達本胺 |
743420-02-2 |
詳細
|
ITKinhibitor2 |
ITK inhibitor 2 |
1309784-09-5 |
詳細
|
C188-9 |
432001-19-9 |
432001-19-9 |
詳細
|
Oxybutynin chloride |
鹽酸奧昔布寧 |
1508-65-2 |
詳細
|
Reltecimod |
Reltecimod |
1447799-33-8 |
詳細
|
DS-3201 |
DS-3201 |
1809336-39-7 |
詳細
|
Atomoxetine HCL |
鹽酸托莫西汀 |
82248-59-7 |
詳細
|
5-Aza-2'-deoxycytidine |
地西他濱 |
2353-33-5 |
詳細
|
ABT 263 |
ABT 263 |
923564-51-6 |
詳細
|
WT-161 |
CS-2547 |
1206731-57-8 |
詳細
|
PI 828 |
8-(4-氨基苯基)-2-(4-嗎啉基)-4H-1-苯并吡喃-4-酮 |
942289-87-4 |
詳細
|
NMDA-IN-1 |
2-[[4-[(2-FLUOROPHENYL)METHYL]-1-PIPERIDINYL]METHYL]-1H-BENZIMIDAZOL-6-OL DIHYDROCHLORIDE |
700878-19-9 |
詳細
|
5-Carboxamidotryptamine maleate |
5-carboxyamidotryptamine maleate |
74885-72-6 |
詳細
|
TOFA |
5-(十四烷基氧)-2-糠酸 |
54857-86-2 |
詳細
|
Acalabrutinib |
阿卡替尼 |
1420477-60-6 |
詳細
|
Capmatinib |
卡馬替尼 |
1029712-80-8 |
詳細
|
Trametinib DMSO solvate |
曲美替尼二甲亞砜 |
1187431-43-1 |
詳細
|
Dabrafenib Mesylate |
達帕菲尼甲磺酸鹽 |
1195768-06-9 |
詳細
|
Ravulizumab |
Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer |
1803171-55-2 |
詳細
|
Research Grade Spesolimab |
司柏索利單抗 |
2097104-58-8 |
詳細
|
Futibatinib |
FGFR抑制劑(FGFR-IN-1) |
1448169-71-8 |
詳細
|
intermediate |
N-(2-(6--羥基-1,2,3,4-四氫萘-2-基)-5-(甲氧基苯基)乙酰胺 |
722520-42-5 |
詳細
|
Brexpiprazole |
依匹哌唑 |
913611-97-9 |
詳細
|
2-Fluoro-4-nitrobenzoic acid |
2-氟-4-硝基苯甲酸 |
403-24-7 |
詳細
|
camlipixant |
BLU-5937 |
1621164-74-6 |
詳細
|
FAP-2286 |
FAP2286 |
2581741-18-4 |
詳細
|
Tislelizumab |
替雷利珠單抗 |
1858168-59-8 |
詳細
|
Baricitinib |
巴瑞克替尼 |
1187594-09-7 |
詳細
|
Leniolisibphosphate |
化合物 T5166L |
1354691-97-6 |
詳細
|
Pemigatinib |
培米加替尼 |
1513857-77-6 |
詳細
|
TP003 |
TP-003 |
628690-75-5 |
詳細
|
IQ3 |
IQ 3 |
312538-03-7 |
詳細
|
PD 180970 |
化合物 PD180970 |
287204-45-9 |
詳細
|
Belzutifan |
PT2977 |
1672668-24-4 |
詳細
|
Remimazolam Tosilate |
甲苯磺酸瑞馬唑侖 |
1425904-79-5 |
詳細
|
Lonodelestat |
LONODELESTAT |
906547-89-5 |
詳細
|
IEM1754dihydrobroMide |
IEM 1754 DIHYDROBROMIDE |
162831-31-4 |
詳細
|
KIRA6 |
CS-2625 |
1589527-65-0 |
詳細
|
PA-8 |
2-amino-5-[3-methoxy-4-(prop-2-en-1-yloxy)phenyl]-3H,4H,5H,6H,7H,8H-pyrido[2,3-d]pyrimidine-4,7-dione |
878437-15-1 |
詳細
|
Fruquintinib|HMPL-013 |
呋喹替尼 |
1194506-26-7 |
詳細
|
(R)-2-((tert-butoxycarbonyl)amino)-3,3,3-trifluoropropanoic acid |
(R)-2-(TERT-BUTOXYCARBONYLAMINO)-3,3,3-TRIFLUOROPROPANOIC ACID |
1354225-89-0 |
詳細
|
Apremilast Impurity 1 |
Apremilast Impurity 57 |
2487573-01-1 |
詳細
|
(S)-2-((tert-Butoxycarbonyl)amino)-3,3,3-trifluoropropanoic acid |
(S)-2-((叔丁氧基羰基)氨基)-3,3,3-三氟丙酸 |
1932644-89-7 |
詳細
|
(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3,3,3-trifluoropropanoicacid |
(R)-2-((9H-芴-9-基)甲氧基)羰基)氨基)-3,3,3-三氟丙酸 |
1704706-86-4 |
詳細
|
GSK 343 |
GSK343 |
1346704-33-3 |
詳細
|
6-ethyl-1,2,3,4-tetrahydroanthraquinone |
2-乙基-5,6,7,8-四氫-9,10-蒽醌 |
15547-17-8 |
詳細
|
Cefepime |
頭孢吡肟 |
88040-23-7 |
詳細
|
Ethyl3-oxo-3-(4-nitrophenyl)propanoate |
對硝基苯甲酰醋酸乙酯 |
838-57-3 |
詳細
|
6-OH-BTA-0 |
6-OH-BTA-0 |
178804-18-7 |
詳細
|
2-Ethyl Anthraquinone |
2-乙基蒽醌 |
84-51-5 |
詳細
|
Xanthene |
氧雜蒽 |
92-83-1 |
詳細
|
Cabergoline EP Impurity D |
卡麥角林雜質D(EP) |
85329-86-8 |
詳細
|
Cabergoline EP Impurity E |
6-Allyldihydronorisolysergic Acid Methyl Ester |
86891-16-9 |
詳細
|
Cabergoline EP Impurity G |
(8β)-N-[3-(Methylamino)propyl]-6-(2-propenyl)-ergoline-8-carboxamide |
478815-26-8 |
詳細
|
Cabergoline EP Impurity F |
Ergoline-8-carboxylic acid, 6-(2-propenyl)-, (8-alpha)- |
86891-15-8 |
詳細
|
Cabergoline EP Impurity J |
Des-N-allylcabergoline |
153415-36-2 |
詳細
|
Cabergoline EP Impurity B |
卡麥角林 EP雜質 B |
166533-36-4 |
詳細
|
Cabergoline EP Impurity C |
(6aR,9R,10aR)-9-N-[3-(dimethylamino)propyl]-4-N-ethyl-9-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4,9-dicarboxamide |
126554-50-5 |
詳細
|
6-Amino-2-(4-dimethylaminophenyl)benzothiazole |
|
909191-20-4 |
詳細
|
Maleimido-mono-amide-DOTA |
DOTA-馬來酰亞胺 |
1006711-90-5 |
詳細
|
Cabergoline EP Impurity A |
6-(2-丙烯基)二氫麥角酸 |
"81409-74-7 |
詳細
|
Ripretinib |
瑞普替尼 |
1442472-39-0 |
詳細
|
EGFR-IN-7 |
5-溴-N4-[5-(二甲基膦基)-6-喹喔啉基]-N2-[2-甲氧基-5-甲基-4-[4-(4-甲基-1-哌嗪基)-1-哌啶基]苯基]-2,4-嘧啶二胺 |
2267329-76-8 |
詳細
|